Leveraging the ability of this ctDNA-Seq technique to reconstruct genome wide copy number profiles [12], we assessed the clonality of resistance driver mutations by first correcting VAFs for the influence of copy-number states and by subsequently calculating the proportion of cancer cells that harbored resistance driver mutations by comparing against TP53 or APC mutations, which are likely clonal. This evidence concerns the gene APC and cancer.